The evolving roles of imaging and fluid biomarkers for Alzheimer disease over the past quarter century

Abstract

Background: At the beginning of the century, Alzheimer disease (AD) biomarkers were only used in research studies and included hippocampal volume and cerebrospinal fluid (CSF) concentrations of Aβ42, total tau, and tau phosphorylated at position 181 ( p ‐tau181).